The total survey results of 2017 by the integrated assestment in category
Digestive system and hepatology / Carminative
Вітрогонні засоби — фармакологічна група лікарських засобів, що зменшують утворення в шлунково-кишковому тракті газів і допомагають їх виведенню при метеоризмі.
Особливо актуальні вітрогінні засоби для грудних дітей в перші місяці їх життя, в період первинного утворення кишкової флори. Біль від здуття животика спричиняє дискомфорт не тільки для малюків, а й для їхніх батьків.
Однак, проблема хворобливого здуття живота і метеоризму може з’явитися в будь-якому віці, в результаті отруєнь або захворювань шлунково-кишкового тракту.
Integrated, “absolute” ratings is calculated
by survey results of 3 respondent groups.
Details…
The Favorites of the Year is determined by the Consumers (non-indifferent public),
Experts (authoritative specialists of this market industry) and
Celebrities Jury (known public figures and celebrities).
In forming of the integrated ratings, the following weight is assumed:
Absolute rank =
(average yearly rank of Consumers × 0.4) +
(rank of Experts × 0.4) +
(rank of Celebrities × 0.2).
The competitor which has taken 1st place in this rating — is the best and the most successful Ukrainian medication of 2017 in the “Carminative” category!
Using this rating is only possible with obligatory link to the source.
This rating was built as a result of the study of social preferences in 2017,
under the “Favorites of Success” Contest in Ukraine and it’s the free information.
In case of full or partial republishing of the information drawn from this rating,
it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications,
or put an active hyperlink to this page in the electronic media. Details…
Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information
roll-call of ad hoc judges etc, can also be obtained from managers of the contest.
Integrated, “absolute” ratings is calculated
by survey results of 3 respondent groups.
View results of current, 2024 year
RSS-feed